Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|October 12, 2023
Unnatural Endotype B PPAPs as Novel Compounds with Activity against <i>Mycobacterium tuberculosis</i>Philipp Peslalz, Mark Grieshober, Frank Kraus, et al.
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
The Pharmacogenomics Journal|August 5, 2015
Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factorsA Emami Riedmaier, O Burk, B A C van Eijck, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.
Pharmacological Research|October 17, 2025
Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liverKathrin Klein, Oliver Burk, Roman Tremmel, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
The Pharmacogenomics Journal|April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeU Gradhand, T Lang, E Schaeffeler, et al.
Breast Cancer Research : BCR|July 15, 2020
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progressionHannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Pharmacogenetics|December 12, 2001
The genetic determinants of the CYP3A5 polymorphismE Hustert, M Haberl, O Burk, et al.
Pharmacogenetics|July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variantsR Eiselt, T L Domanski, A Zibat, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|October 12, 2023
Unnatural Endotype B PPAPs as Novel Compounds with Activity against <i>Mycobacterium tuberculosis</i>Philipp Peslalz, Mark Grieshober, Frank Kraus, et al.
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
The Pharmacogenomics Journal|August 5, 2015
Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factorsA Emami Riedmaier, O Burk, B A C van Eijck, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.
Pharmacological Research|October 17, 2025
Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liverKathrin Klein, Oliver Burk, Roman Tremmel, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
The Pharmacogenomics Journal|April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeU Gradhand, T Lang, E Schaeffeler, et al.
Breast Cancer Research : BCR|July 15, 2020
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progressionHannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Pharmacogenetics|December 12, 2001
The genetic determinants of the CYP3A5 polymorphismE Hustert, M Haberl, O Burk, et al.
Pharmacogenetics|July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variantsR Eiselt, T L Domanski, A Zibat, et al.
Pageof 21